Fig. 1: Heparan sulfate proteoglycan (HSPG)-dependent internalization of soluble extracellular tau aggregates by brain microvascular endothelial cells triggers endogenous tau phosphorylation (Thr231).

A–C Soluble aggregated tau internalization triggers endogenous tau phosphorylation in primary human brain microvascular endothelial cells (HBEC). A Soluble tau aggregates accumulate in brain microvasculature of P301S(PS19) mice. Representative images of cortical brain sections from 8-month-old male and female P301S(PS19) and WT controls showing soluble tau aggregates (T22, green) and total tau (Tau5, cyan) immunoreactivity in lectin-stained microvasculature (red). Nine independent samples (three brain sections from each of three mice) were examined over three independent experiments. B Representative images of primary HBEC exposed to soluble aggregates of V5-tagged recombinant human tau-441 or vehicle (control) in the presence or absence of heparin, immunostained with antibodies for V5 (green) and α/β-tubulin (red), and counterstained with DAPI (blue). Scale bar is 200 µm. Nine independent samples were examined over 3 independent experiments. C Representative electropherograms from capillary electrophoresis immunoassays for phosphorylated tau (T231) and β-actin in lysates from HBEC treated with recombinant human cytokeratin-8 (KRT8), monomeric tau protein (M. Tau), unlabeled soluble tau aggregates (O.Tau), or vehicle (control). D Quantitative analyses of data in C (F(3,22) = 3.115, ANOVA, p = 0.047. Control vs. O. Tau, *, P < 0.05. Control, n = 12; KRT8, n = 4; M. Tau, n = 4, O. Tau, n = 6 biologically independent samples examined over 6 independent experiments. Data are means ± SEM. E, F Atomic force microscopy profiling of tau. E Representative AFM images of field fragments with soluble tau aggregates, tagged (V5) and untagged. F Size distribution of tau particles as measured by AFM show overlapping distributions of soluble tau aggregates (>12 nm in length) in non-tagged and V5-tagged soluble tau aggregate preparations (Soluble tau aggregates V5, n = 405 particles; soluble tau aggregates, n = 403 particles [i.e., biologically independent samples (particles measured) examined over 1 independent experiment]. Data are frequency profiles. For post-hoc analyses, lack of a specific P value in the legend reflects the information reported by GraphPad Prism Version 9.4.0.